ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Net Debt Over TimeCompressed
Percentile Rank36
3Y CAGR-45.0%
5Y CAGR-25.9%
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

3Y CAGR
-45.0%/yr
vs +14.2%/yr prior
5Y CAGR
-25.9%/yr
Recent deceleration
Acceleration
-59.2pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
2025$39.61M-91.7%
2024$479.23M+642.4%
2023$64.55M-72.9%
2022$238.29M+27.4%
2021$187.07M+5.2%
2020$177.82M+44.1%
2019$123.42M-11.8%
2018$140.01M-17.8%
2017$170.36M+82.6%
2016$93.28M-